These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 8355860

  • 1. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R, Irace L, Perna B, Caruso C, Guida M, Iacono A.
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [Abstract] [Full Text] [Related]

  • 2. [The regression of left ventricular hypertrophy and improvement in diastolic filling during antihypertensive therapy with cilazapril].
    Sabatini D, Fazio S, Cittadini A, Biondi B, Lucariello A, Picano T, Saccà L.
    Cardiologia; 1993 Jun; 38(6):377-81. PubMed ID: 8402747
    [Abstract] [Full Text] [Related]

  • 3. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R, Solorio S, Vargas-Salado E, Aguirre-Vázquez C, Hernández-González MA, Olvera-Lopez JA, Rodríguez-Mariscal L, Luna-Ruiz MA, Guillén Contreras JM, Murillo Ortiz BO.
    Arch Cardiol Mex; 2008 Jun; 78(4):392-9. PubMed ID: 19205547
    [Abstract] [Full Text] [Related]

  • 4. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D, Rumboldt Z, Bagatin J, Polić S.
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension.
    Porcellati C, Verdecchia P, Schillaci G, Boldrini F, Motolese M.
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):187-97. PubMed ID: 1830037
    [Abstract] [Full Text] [Related]

  • 6. [Effect of cilazapril in patients with essential hypertension: effect on cardiac hypertrophy].
    Abrahám G, Pogátsa-Murray G, Forster T, Csanády M, Sonkodi S.
    Orv Hetil; 1996 Jul 21; 137(29):1583-6. PubMed ID: 8757070
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of regression of left ventricular hypertrophy after antihypertensive therapy. Comparative echo-Doppler study of ace inhibitors and calcium antagonists].
    Totteri A, Scopelliti G, Campanella G, Bertini M, Castro R, Pintus G, Jommi E.
    Minerva Cardioangiol; 1993 Jun 21; 41(6):231-7. PubMed ID: 8361609
    [Abstract] [Full Text] [Related]

  • 8. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA, Shlyakhto EV, Konrady AO, Macsimova TA, Zaharov DV, Rudomanov OG.
    Med Sci Monit; 2000 Jun 21; 6(2):309-13. PubMed ID: 11208328
    [Abstract] [Full Text] [Related]

  • 9. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V, Okin PM, Bella JN, Wachtell K, Oikarinen L, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2006 Oct 21; 24(10):2079-84. PubMed ID: 16957569
    [Abstract] [Full Text] [Related]

  • 10. [Reparative effects of ACE inhibitors on the heart].
    Dietz R, Haberbosch W, Osterziel KJ, Förderer T, Busch C.
    Klin Wochenschr; 1992 Oct 21; 69 Suppl 29():16-24. PubMed ID: 1535402
    [Abstract] [Full Text] [Related]

  • 11. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE, Johnson DB, Barilla F, Blackwell GG, Orr R, Roney M, Stanley AW, Pohost GM, Dell'Italia LJ.
    Am Heart J; 1998 Aug 21; 136(2):269-75. PubMed ID: 9704689
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).
    Wachtell K, Palmieri V, Gerdts E, Bella JN, Aurigemma GP, Papademetriou V, Dahlöf B, Aalto T, Ibsen H, Rokkedal JE, Devereux RB.
    Am J Cardiol; 2010 Oct 01; 106(7):999-1005. PubMed ID: 20854964
    [Abstract] [Full Text] [Related]

  • 13. [Improvement in diastolic function in hypertensive patients with left ventricular hypertrophy with inhibitors of the angiotensin converting enzyme].
    Sagastagoitia JD, Morillas M, Martínez A, Lage E, Pallarés C, Ugartemendía C, Asín E, Barrios V, Julia J, Sánchez P, Calvo C, González J, Piña C, García-Barbal J, Arnau C.
    Rev Clin Esp; 1998 Jan 01; 198(1):15-22. PubMed ID: 9580230
    [Abstract] [Full Text] [Related]

  • 14. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI.
    Blood Press Monit; 2007 Apr 01; 12(2):87-94. PubMed ID: 17353651
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V, Devereux RB.
    Minerva Cardioangiol; 2002 Jun 01; 50(3):169-74. PubMed ID: 12107398
    [Abstract] [Full Text] [Related]

  • 16. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Hanehira T, Yoshikawa J.
    Int J Clin Pharmacol Ther; 1997 Jan 01; 35(1):38-42. PubMed ID: 9021441
    [Abstract] [Full Text] [Related]

  • 17. Improvement of diastolic filling in hypertensive patients treated with cilazapril.
    Haberbosch W, De Simone R, Dietz R, Waas W, Tillmanns H, Kübler W.
    J Cardiovasc Pharmacol; 1991 Jan 01; 17 Suppl 2():S159-62. PubMed ID: 1715471
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
    Tuncer M, Guntekin U, Gunes Y, Gumrukcuoglu HA, Eryonucu B.
    Adv Ther; 2008 Jun 01; 25(6):619-26. PubMed ID: 18563311
    [Abstract] [Full Text] [Related]

  • 19. [Course of the left ventricular mass in a population of 893 hypertensive patients. Effects of treatment with perindopril].
    Revel F, Gallois H, Le Coz Y, Richard R, Ollivier JP.
    Ann Cardiol Angeiol (Paris); 1994 Dec 01; 43(10):594-9. PubMed ID: 7864552
    [Abstract] [Full Text] [Related]

  • 20. [Effect of ramipril on the glucose/insulin coefficient and the ventricular mass index in patients with light to moderate arterial hypertension].
    Germán Cardona-Muñoz E, Noriega-Arellano J, Hernández-Chávez A, López-Alvarado A, González-Ortiz M, Martínez-Abundis E, Delgado Hurtado JM, Ramos-Remus C, Gamez-Nava I, Ayub-Ayala M.
    Arch Cardiol Mex; 2003 Dec 01; 73(1):24-30. PubMed ID: 12820491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.